# EDGAR Filing Document

**Accession Number:** 0001490978
**File Stem:** 0001490978-25-000082
**Filing Date:** 2025-6
**Character Count:** 7608
**Document Hash:** 74c1a171f8721effc4cf18552c12c575
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001490978-25-000082.hdr.sgml**: 20250618

**ACCESSION NUMBER**: 0001490978-25-000082

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250618

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250618

**DATE AS OF CHANGE**: 20250618

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Schrodinger, Inc.
- **CENTRAL INDEX KEY:** 0001490978
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 954284541
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39206
- **FILM NUMBER:** 251056999

**BUSINESS ADDRESS:**
- **STREET 1:** 1540 BROADWAY
- **STREET 2:** 24TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 503-299-1150

**MAIL ADDRESS:**
- **STREET 1:** 1540 BROADWAY
- **STREET 2:** 24TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

?xml version='1.0' encoding='ASCII'? sdgr-20250618

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

________________________________________

**FORM 8-K**

________________________________________

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): June 18, 2025**

________________________________________

**Schrodinger, Inc.**

**(Exact name of Registrant as Specified in Its Charter)**

________________________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-39206** | **95-4284541** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **001-39206** | **(I.R.S. Employer**<br>**Identification No.)** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(Commission File Number)** | **(I.R.S. Employer**<br>**Identification No.)** |
| **1540 Broadway, 24th Floor**<br>**New York, NY** | | **10036** |
| **(Address of principal executive offices)** | | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (212) 295-5800**

**Not Applicable** 

**(Former Name or Former Address, if Changed Since Last Report)**

________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, par value $0.01 per share | SDGR | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company □

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

**Item 5.07 Submission of Matters to a Vote of Security Holders.**

At the 2025 Annual Meeting of Stockholders of Schrödinger, Inc. (the "Company"), held on June 18, 2025 (the "Annual Meeting"), the Company's stockholders voted on the three proposals set forth below. A more detailed description of each proposal is set forth in the Company's <u>[Proxy Statement for the Annual Meeting filed with the Securities and Exchange Commission on April 24, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001490978/000149097825000047/sdgr-20250423.htm)</u>.

Holders of the Company's common stock were entitled to one vote per share of common stock on each matter brought before the Annual Meeting. Holders of the Company's limited common stock were entitled to one vote per share of limited common stock on each matter brought before the Annual Meeting, except that each share of limited common stock was not entitled to vote on the election of directors.

**Proposal 1 – Election of Four Class II Directors**

The Company's stockholders elected Jeffrey Chodakewitz, Michael Lynton, Nancy A. Thornberry, and Bridget van Kralingen as Class II directors of the board of directors, each to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified. The results of the stockholders' vote with respect to the election of such Class II directors were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Nominee</u>** | **<u>Number of Shares of Common Stock FOR</u>** | **<u>Number of Shares of Common Stock AGAINST</u>** | **<u>Number of Shares of Common Stock ABSTAINING</u>** | **<u>BROKER NON-VOTES</u>** |
| Jeffrey Chodakewitz | 44010885 | 633124 | 27115 | 7885651 |
| Michael Lynton | 32354605 | 12288938 | 27581 | 7885651 |
| Nancy A. Thornberry | 44012696 | 612247 | 46181 | 7885651 |
| Bridget van Kralingen | 44203761 | 440684 | 26679 | 7885651 |

---

**Proposal 2 – Advisory Vote on Executive Compensation**

The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers. The results of the stockholders' non-binding, advisory vote with respect to compensation paid to the Company's named executive officers were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **<u>Number of Shares FOR</u>** | **<u>Number of Shares AGAINST</u>** | **<u>Number of Shares ABSTAINING</u>** | **<u>BROKER NON-VOTES</u>** |
| Common Stock | 41593958 | 3028650 | 48516 | 7885651 |
| Limited Common Stock | 9164193 | 0 | 0 | 0 |
| Total | 50758151 | 3028650 | 48516 | 7885651 |

---

**Proposal 3 – Ratification of the Appointment of KPMG LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025**

The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The results of the stockholders' vote with respect to such ratification were as follows:

------

---

| | | | |
|:---|:---|:---|:---|
| | **<u>Number of Shares FOR</u>** | **<u>Number of Shares AGAINST</u>** | **<u>Number of Shares ABSTAINING</u>** |
| Common Stock | 52190272 | 335203 | 31300 |
| Limited Common Stock | 9164193 | 0 | 0 |
| Total | 61354465 | 335203 | 31300 |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **Schrödinger, Inc.** | **Schrödinger, Inc.** |
| Date: June 18, 2025 | By: | /s/ Yvonne Tran |
|  |  | Yvonne Tran |
|  |  | Executive Vice President and Chief Legal Officer |

---